Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Medtronic
Moodys
Merck
Mallinckrodt

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Litigation Details for Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. (D. Del. 2018)

See Plans and Pricing

« Back to Dashboard

Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. (D. Del. 2018)

Docket   Start Trial Date Filed 2018-05-07
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Colm F. Connolly
Jury Demand None Referred To
Parties MSN LABORATORIES PRIVATE LIMITED; MSN PHARMACEUTICALS INC.; VANDA PHARMACEUTICALS INC.
Patents 10,071,977; 10,149,829; 9,060,995; 9,539,234; 9,549,913; 9,730,910; 9,855,241; RE46,604
Attorneys Bryce A. Cooper; Daniel J. Klein; David A. Bilson; Derek James Fahnestock; Eric A. Stone; Jennifer R. Deneault; John C. Phillips , Jr.; Josephine Young; Karen Jacobs; Kevin E. Warner; Kira A. Davis; Nicholas Groombridge; Reid Smith
Firms Morris, Nichols, Arsht & Tunnell; Phillips, Goldman, McLaughlin & Hall, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 4 Patent/Trademark Report to Commissioner of Patents Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE46,604; 9,060,995; 9,539,234; 9,… 7 May 2018 1:18-cv-00690 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
2018-12-11 43 or more claims of Vanda’s U.S. Patent No. 10,071,977 (“the ’977 patent”), which, in relevant part, generally… U.S. Patent No. 10,071,977 56. Vanda is the owner…9,855,241; 10,071,977) 36. The allegations above…of Vanda’s U.S. Patent Nos. RE46,604 (“the RE604 patent”); 9,060,995 (“the ’995 patent”); 9,539,234 (“…(“the ’234 patent”); 9,549,913 (“the ’913 patent”); 9,730,910 (“the ’910 patent”); and 9,855,241 (“the External link to document
0000-00-00 44 9,539,234 ;9,549,913 ;9,730,910 ;9,855,241 ;10,071,977 Adding 10,071,977 by Amended Complaint. (fms) (Entered… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): RE46,604 ;9,060,995… 7 May 2018 1:18-cv-00690 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 47 Initial Infringement Contentions for U.S. Patent No. 10, 071,977 filed by Vanda Pharmaceuticals Inc..(Fahnestock… 7 May 2018 1:18-cv-00690 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 52 Invalidity Contentions Concerning U.S. Patent No. 10,071,977 filed by MSN Laboratories Private Limited… 7 May 2018 1:18-cv-00690 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Harvard Business School
Merck
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.